CXCL5 promotes mitomycin C resistance in non-muscle invasive bladder cancer by activating EMT and NF-κB pathway
Authors:
- 1 April 2018
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 498 (4) , 862-868
Abstract
No abstract availableKeywords
Funding Information
- Beijing Municipal Administration of Hospitals (QML20160104)
- National Natural Science Foundation of China (61401290)
- Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support (ZYLX201604)
This publication has 22 references indexed in Scilit:
- CXCL5 knockdown expression inhibits human bladder cancer T24 cells proliferation and migrationBiochemical and Biophysical Research Communications, 2014
- Molecular mechanisms of epithelial–mesenchymal transitionNature Reviews Molecular Cell Biology, 2014
- Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinomaHepatology, 2012
- Microparticles and their emerging role in cancer multidrug resistanceCancer Treatment Reviews, 2012
- Expression profile of E-cadherin and N-cadherin in non-muscle-invasive bladder cancer as a novel predictor of intravesical recurrence following transurethral resectionUrologic Oncology: Seminars and Original Investigations, 2012
- Estrogen receptor β (ERβ) is a novel prognostic marker of recurrence survival in non-muscle-invasive bladder cancer potentially by inhibiting cadherin switchWorld Journal of Urology, 2012
- Transcription factors that mediate epithelial–mesenchymal transition lead to multidrug resistance by upregulating ABC transportersCell Death & Disease, 2011
- Adipose tissue-derived stem cells secrete CXCL5 cytokine with chemoattractant and angiogenic propertiesBiochemical and Biophysical Research Communications, 2010
- Inflaming metastasisNature, 2008
- Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer.Journal of Clinical Investigation, 1998